Does 18F-FAPI PET/CT imaging predict 5-year risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
18F-FAPI PET/CT imaging shows intense and heterogeneous activity in hypertrophic cardiomyopathy, which is significantly associated with the 5-year risk of sudden cardiac death.
= .03). Conclusion Fibroblast activation protein inhibitor (FAPI) PET/CT imaging indicated intense and heterogeneous activity in hypertrophic cardiomyopathy, and FAPI uptake was associated with 5-year risk of sudden cardiac death. © RSNA, 2022
Wang et al. (2022) studied this question.